Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primaquine for Vivax Malaria Relapse in Afghanistan
NCT01178021Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Aug 2009
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of primaquine in Plasmodium vivax malaria (2 arms), sponsored by University of Oxford. Primary endpoint: Secondary vivax attack at 1 year. Started Aug 2009; status: completed.
02
Drugs
primaquine
03
Conditions
Plasmodium vivax malaria
Beyond the preview
Go deeper on NCT01178021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01178021.